{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:02:06Z","timestamp":1759971726384,"version":"build-2065373602"},"reference-count":0,"publisher":"Journal of Nepal Medical Association (JNMA)","issue":"287","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nepal Med Assoc"],"abstract":"<jats:p>Introduction: The respiratory infection with COVID-19 caused by the novel coronavirus SARS-CoV-2, emerged in December 2019 and was later declared a global pandemic by the world health organization. Clinical observations suggest the role of ABO blood types in susceptibility to COVID-19 infection. The study was designed to find the proportion of blood group distribution across the severity of COVID-19 patients.\nMethods: This is an observational cross-section study conducted at a tertiary care hospital. All COVID-19 patient visiting hospital within January to December 2021 were included in the study. Their demographic profile, blood group and COVID-19 severity were recorded. Descriptive analysis of the date was done.\nResults: There were 399 confirmed case of COVID-19 during study period, out of which 278 (69.7%) were male and 198 (49.62%) were aged between 21\u201340 years. There were 78 (31.45%) amongst mild COVID-19 and 32 (39.04%) amongst severe COVID-19 (Bilateral Pneumonia) having A positive blood group.\nConclusions: The study suggests that patients with blood group A positive were more in the mild COVID-19, severe COVID-19 group.<\/jats:p>","DOI":"10.31729\/jnma.9106","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:06:42Z","timestamp":1751350002000},"page":"496-501","source":"Crossref","is-referenced-by-count":0,"title":["Blood Group Type and COVID-19 Severity at Tertiary Care Centre, Nepal: An Observational Study"],"prefix":"10.31729","volume":"63","author":[{"given":"Nabin","family":"Rauniyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rojina","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16919","published-online":{"date-parts":[[2025,7,1]]},"container-title":["Journal of Nepal Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/www.jnma.com.np\/jnma\/index.php\/jnma\/article\/download\/9106\/5331","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jnma.com.np\/jnma\/index.php\/jnma\/article\/download\/9106\/5331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:31:48Z","timestamp":1759941108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jnma.com.np\/jnma\/index.php\/jnma\/article\/view\/9106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":0,"journal-issue":{"issue":"287","published-online":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.31729\/jnma.9106","relation":{},"ISSN":["1815-672X","0028-2715"],"issn-type":[{"type":"electronic","value":"1815-672X"},{"type":"print","value":"0028-2715"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}